Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.
Lassen MR, Borris LC, Anderson BS, Jensen HP, Skejø Bro HP, Andersen G, Petersen AO, Siem P, Hørlyck E, Jensen BV, Thomsen PB, Hansen BR, Erin-Madsen J, Møller JC, Rotwitt L, Christensen F, Nielsen JB, Jørgensen PS, Paaske B, Tørholm C, Hvidt P, Jensen NK, Nielsen AB, Appelquist E, Tjalve E, et al.
Lassen MR, et al. Among authors: nielsen ab, nielsen jb.
Thromb Res. 1998 Mar 15;89(6):281-7. doi: 10.1016/s0049-3848(98)00018-8.
Thromb Res. 1998.
PMID: 9669750
Clinical Trial.